ElisabethIljasHeathMDFACP

Oncology • Detroit, MI

Genitourinary Oncology, Hematologic Oncology

Associate Center Director, Translational Science, Karmanos Cancer Institute

Join to view full profile

Dr. Heath is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Heath's full profile

Already have an account?

Office
Karmanos Cancer Center
4100 John R Hwcrc 4th Fl
Detroit, MI 48201
Phone+1 313-576-8624

Fax+1 313-576-8767
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1993 - 1996
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993

Certifications & Licensure

MI State Medical License 2003 - 2025
MD State Medical License 1996 - 2004
VA State Medical License 1994 - 2004
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
Completed
Phase 2
Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy Start of enrollment: 2005 Aug 01
Completed
Phase 1
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Active, not recruiting
Phase 1, Phase 2
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2007 Nov 01
Terminated
Phase 2
Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy Start of enrollment: 2009 Aug 01
Completed
Phase 2
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Start of enrollment: 2009 Sep 01
Suspended
Not Applicable
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers Start of enrollment: 2009 Nov 01
Completed
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy Start of enrollment: 2011 Jan 01
Completed
Phase 2
Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Start of enrollment: 2011 Jul 01
Completed
Phase 1, Phase 2
Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer Start of enrollment: 2011 Aug 01
Unknown status
Phase 1, Phase 2
Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2011 Oct 01
Completed
Phase 1, Phase 2
A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01
Terminated
Phase 2
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer Start of enrollment: 2013 Mar 01
Completed
Not Applicable
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer Start of enrollment: 2014 May 01
Completed
Phase 2
Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer Start of enrollment: 2015 Jul 01
Completed
Phase 1
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2018 Mar 08
Completed
Phase 2
A Study of Olaparib and Durvalumab in Prostate Cancer Start of enrollment: 2019 Mar 07
Terminated
Phase 2
First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2020 Jul 17
Terminated
Phase 1
ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2019 Nov 13
Recruiting
Phase 2
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Start of enrollment: 2021 Mar 03
Recruiting
Phase 2
International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew K Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Gra...> ;JCO Precision Oncology. 2024 Apr 1
A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer.
Marianne Keessen, Robert Dreicer, Tomas Buchler, Péter F Árkosy, Tibor Csöszi, Pawel Wiechno, Evgeny Kopyltsov, Sergey V Orlov, Alexey Plekhanov, Maria Smagina, Sergei...> ;European Journal of Cancer. 2024 Mar 11
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Chen, N., McGrath, C., Ericsson, C., Vaselkiv, J., Rencsok, E., Stopsack, K., Guard, H., Autio, K., Rathkopf, D., Enting, D., Bitting, R., Mateo, J., Githiaka, C., Chi...> ;Cancer Epidemiology, Biomarkers & Prevention. 2024 Mar 1
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek...> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 28
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Wei, S., Krause, H., Geynisman, D., Elliott, A., Kutikov, A., Uzzo, R., Pei, J., Barata, P., Carneiro, B., Heath, E., Ryan, C., Farrell, A., Nabhan, C., Ali-Fehmi, R.,...> ;Modern Pathology. 2024 Feb 1
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Rencsok, E., Slopen, N., McManus, H., Autio, K., Morgans, A., McSwain, L., Barata, P., Cheng, H., Dreicer, R., Gerke, T., Green, R., Heath, E., Howard, L., McKay, R., ...> ;Cancer Research Communications. 2024 Jan 8
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
Msaouel, P., Sweis, R., Bupathi, M., Heath, E., Goodman, O., Hoimes, C., Milowsky, M., Davis, N., Kalebasty, A., Picus, J., Shaffer, D., Mao, S., Adra, N., Yorio, J., ...> ;European Urology Oncology. 2023 Dec 16
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Petrylak, D., Eigl, B., George, S., Heath, E., Hotte, S., Chism, D., Nabell, L., Picus, J., Cheng, S., Appleman, L., Sonpavde, G., Morgans, A., Pourhosseini, P., Wu, R...> ;Clinical Cancer Research. 2024 Jan 5
The impact of high intensity interval training in a diverse group of cancer survivors: CAPABLE, a pilot study.
Jennifer L Beebe-Dimmer, David G Finlay, Julie J Ruterbusch, Tara Baird, Michael S Simon, Judith Abrams, Felicity W K Harper, Izabela Podgorski, Elisabeth I Heath> ;Preventive Medicine Reports. 2023 Oct 1
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
Huma Q Rana, Jill E Stopfer, Michelle Weitz, Lindsay Kipnis, Diane R Koeller, Samantha Culver, Joanna Mercado, Rebecca Sue Gelman, Meghan Underhill-Blazey, Bradley A M...> ;JCO Oncology Practice. 2023 Nov 1
8 citations
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Bassel Nazha, Tony Zhuang, Sharon Wu, Jacqueline T Brown, Daniel Magee, Bradley C Carthon, Omer Kucuk, Chadi Nabhan, Pedro C Barata, Elisabeth I Heath, Charles J Ryan,...> ;Cancer. 2023 Dec 15
4 citations
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Christopher W Ryan, Catherine M Tangen, Elisabeth I Heath, Mark N Stein, Maxwell V Meng, Ajjai S Alva, Sumanta K Pal, Igor Puzanov, Joseph I Clark, Toni K Choueiri, Ne...> ;Lancet. 2023 Sep 23
1 citations
Using Music as a Tool for Distress Reduction During Cancer Chemotherapy Treatment.
Felicity W K Harper, Allison S Heath, Tanina Foster Moore, Seongho Kim, Elisabeth I Heath> ;JCO Oncology Practice. 2023 Dec 1
1 citations
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Emily M Rencsok, Natalie Slopen, Karen Autio, Alicia Morgans, Lawrence McSwain, Pedro Barata, Heather H Cheng, Robert Dreicer, Elisabeth Heath, Rana R McKay, Mark Pome...> ;Quality of Life Research. 2023 Nov 1
2 citations
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations.
Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew...> ;JCO Precision Oncology. 2023 Jul 1
3 citations
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Th...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
Experience with the US health care system for Black and White patients with advanced prostate cancer.
Emily M Rencsok, Konrad H Stopsack, Natalie Slopen, Folakemi T Odedina, Camille Ragin, Joel Nowak, Lawrence McSwain, Jan Manarite, Elisabeth Heath, Daniel J George, Ph...> ;Cancer. 2023 Aug 15
F-sodium fluoride positron emission tomography quantitation of bone metastases in African American and non-African American men with metastatic prostate cancer.
Julian Hazelton, Seongho Kim, Julie L Boerner, Izabela Podgorski, Timothy Perk, Frank Cackowski, Hussein D Aoun, Elisabeth I Heath> ;The Prostate. 2023 Sep 1
1 citations
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Justin Hwang, Xiaolei Shi, Andrew Elliott, Taylor E Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, All...> ;Clinical Cancer Research. 2023 Jul 14
17 citations
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, An...> ;The Lancet. Oncology. 2023 May 1
Selective ablation of TRA-1-60pluripotent stem cells suppresses tumor growth of prostate cancer.
Jordan M White, Nicholas Ramos, Allen-Dexter Saliganan, Joon-Yong Chung, Meghan Bell, Jacob Lindquist, Kayla Conner, Wendy N Wiesend, Michael Schopperle, Steve M Patri...> ;Theranostics. 2023 Jan 1
5 citations
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
Susan Eggly, Nicole Senft, Seongho Kim, Elisabeth I Heath, Hyejeong Jang, Tanina F Moore, Fatmeh Baidoun, Mark A Manning, Louis A Penner, Terrance L Albrecht, Michael ...> ;Cancer Medicine. 2023 Apr 1
3 citations
Development and pilot test of a physician-focused cancer clinical trials communication training intervention.
Susan Eggly, Mark Manning, Nicole Senft, Tanina Foster Moore, Terrance L Albrecht, Louis A Penner, Elisabeth Heath, Michael A Carducci, Dina G Lansey, Lauren M Hamel> ;PEC Innovation. 2022 Dec 1
2 citations
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Pro...
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Jason W D Hearn, Steven Miller, James A Proudfoot, Matthew P Deek, Ryan Phillips, Tamara Lotan...> ;Journal of Clinical Oncology. 2023 Feb 20
Join now to see all

Journal Articles

Willingness to Discuss Clinical Trials Among Black vs White Men with Prostate Cancer
Elisabeth Heath, MD, JAMA Oncology

Press Mentions

Intervention to Improve Patient-Physician Communication May Improve Black Patient Participation in Clinical Trials, Study Led by Karmanos ResearcherFebruary 27th, 2023
Karmanos Receives Renewal of Membership in Prestigious Prostate Cancer Clinical Trials ConsortiumOctober 24th, 2022
Free Community Educational Event Features Experts Highlighting the Future of Cancer CareOctober 2nd, 2022
Join now to see all